FACTORS AFFECTING INTERMEDIATE-DOSE METHOTREXATE (MTX) CLEARANCE (CL) IN THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)

被引：0
|
作者：
CROM, WR [1 ]
GLYNN, AM [1 ]
EVANS, WE [1 ]
机构：
[1] ST JUDE CHILDRENS RES HOSP,DIV PHARMACEUT,PHARMACOKINET & PHARMACODYNAM SECT,MEMPHIS,TN 38101
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [41] ASSOCIATION OF ACQUIRED METHOTREXATE (MTX) RESISTANCE WITH ALTERED DIHYDROFOLATE REDUCTASE (DHFR) IN ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
    SKEEL, RT
    BERTINO, JR
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 934 - &
  • [42] METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC-LEUKEMIA
    EVANS, WE
    STEWART, CF
    CHEN, CH
    CROM, WR
    BOWMAN, WP
    ABROMOWITCH, M
    SIMONE, JV
    LANCET, 1984, 1 (8373): : 359 - 362
  • [43] DISAPPEARANCE OF PREDICTIVE VALUE OF PROGNOSTIC FACTORS FOR CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    SATHER, HN
    COCCIA, P
    NESBIT, M
    LEVEL, C
    HAMMOND, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 330 - 330
  • [44] CNS PROPHYLAXIS WITH HIGH DOSE METHOTREXATE IN HIGH-RISK CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA
    COHEN, IJ
    ZAIZOV, R
    MATOTH, Y
    PEDIATRIC RESEARCH, 1978, 12 (01) : 65 - 65
  • [45] VARIABILITY IN DRUG CLEARANCE CAN INFLUENCE RISK OF RELAPSE IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    EVANS, WE
    ABROMOWITCH, M
    LOOK, AT
    WILLIAMS, D
    CROM, WR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 194 - 194
  • [46] METHOTREXATE (MTX) - PHARMACOLOGY IN PATIENTS RECEIVING INTENSIVE MTX/6MERCAPTOPURINE (6MP) CONSOLIDATION FOR ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - A PEDIATRIC ONCOLOGY GROUP-STUDY
    GRAHAM, M
    CAMITTA, B
    LAUER, S
    LEVENTHAL, B
    CASPER, J
    CIVIN, C
    CHEO, D
    ZUHARUK, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 226 - 226
  • [47] SURVIVAL IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - INFLUENCE OF PROTOCOL AND PLACE OF TREATMENT
    MEADOWS, AT
    HOPSON, R
    LUSTBADER, E
    EVANS, AE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 425 - 425
  • [48] TREATMENT OF ACUTE MYELOID-LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE
    BRITOBABAPULLE, F
    CATOVSKY, D
    NEWLAND, AC
    GOLDMAN, JM
    GALTON, DAG
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 51 - 52
  • [49] EFFICACY OF HIGH-DOSE METHOTREXATE IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - ANALYSIS BY CONTEMPORARY RISK CLASSIFICATIONS
    ABROMOWITCH, M
    OCHS, J
    PUI, CH
    FAIRCLOUGH, D
    MURPHY, SB
    RIVERA, GK
    BLOOD, 1988, 71 (04) : 866 - 869
  • [50] THE MUNICH PROTOCOL FOR THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDHOOD, ALL 77-02
    GRAUBNER, UB
    HAAS, RJ
    JANKA, G
    GAEDICKE, G
    KOHNE, E
    RIEBER, EP
    KLINISCHE PADIATRIE, 1985, 197 (03): : 207 - 214
12345